China

Global leader in cell and gene therapy clinical trials, with the world's largest CAR-T trial pipeline including solid tumor CAR-Ts (Claudin 18.2, GPC3, CEA, GD2). Home to first-approved gene therapy (Gendicine) and major proton/heavy ion centers.